Insider Trading & Ownership of Lawrence Otto Klein

Location: Menlo Park, CA
Summary: The estimated net worth of Lawrence Otto Klein is at least $4,457,352 dollars as of 01 May 2025. Lawrence Otto Klein is the Chief Executive Officer, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $2.54M. Lawrence Otto Klein is the CBO & COO of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $1.67M. Lawrence Otto Klein is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $229.3K. Lawrence Otto Klein is the Director of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $15.9K.
Signature: /s/ Elizabeth Balta, as attorney-in-fact for Lawrence Otto Klein
All Insider Reports: All Insider Reports

Notify me when Lawrence Otto Klein files a new Insider Trading report.

Ownership of Lawrence Otto Klein

Symbol	Company	Relationship	Holdings Value	Report Period
ORKA	Oruka Therapeutics, Inc.	Chief Executive Officer, Director	$2,537,240	22 Jan 2025
CRSP	CRISPR Therapeutics AG	Cbo & Coo	$1,674,890	16 Aug 2022
JBIO	Jade Biosciences, Inc.	Director	$229,331	29 Apr 2025
JSPR, JSPRW	Jasper Therapeutics, Inc.	Director	$15,891	07 Jun 2023
DYN	Dyne Therapeutics, Inc.	Director		05 Jul 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.